FIELD: pharmacology.
SUBSTANCE: invention relates to the mixtures represented by the general formula 
or to its pharmaceutically acceptable salts that are able to find an application in treatment of the diseases related to dipeptidyl peptidase IV. In the formula I R1 is selected from the hydrogen atom, the fluorine atom, the chlorine atom, the bromine atom, the iodine atom or the cyano group. The invention also relates to the mentioned mixtures production process and to its application in obtaining the therapeutic agent for the connected to dipeptidyl peptidase IV diseases treatment.
EFFECT: compound application efficiency upgrading.
12 cl, 4 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| XANTHINE DERIVATIVE | 2016 |
|
RU2709348C2 |
| AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES | 2010 |
|
RU2550508C2 |
| DICYCLOAZAALKANE DERIVATIVES, METHODS FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2008 |
|
RU2487866C2 |
| CYCLOALKYLAMINE DERIVATIVES | 2005 |
|
RU2402526C2 |
| DERIVATIVE OF 2-CYANO-4-FLUOROPYRROLIDINE AND ITS SALT | 2003 |
|
RU2288222C2 |
| DERIVATIVES OF PYRIDINE AND QUINOLINE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, USING COMPOUNDS FOR TREATMENT OF DPP-IV-ASSOCIATED DISEASES | 2003 |
|
RU2285693C2 |
| 4-AMINOPYPERIDINE DERIVATIVES | 2005 |
|
RU2396257C2 |
| SUBSTITUTED BENZYLAMINOPIPERIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2152930C2 |
| CRYSTAL FORM α OF COMPOUND OF MONOBENZOATE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 2015 |
|
RU2677660C2 |
| PURINE DERIVATIVES APPLICABLE FOR TREATING FAP-RELATED (FIBROBLAST ACTIVATOR PROTEIN) DISEASES | 2008 |
|
RU2569749C2 |
